Latest Stock Market News

Swedish fund EQT Partners is set to sell its five-year-old investment in US-based healthcare IT services firm AGS Health, aiming for a valuation of $750 million-$780 million. The sale process, managed by JP Morgan and Bank of America, will launch early next year. AGS Health provides revenue cycle management solutions and employs 12,000 people across multiple locations.

​​The regulator had undertaken a detailed investigation by certain entities from January 1,2021 to October 31,2022, who were consistently placing orders ahead of the big clients including Bharat Kanaiyalal Sheth Family Trust in the cash segment and were squaring off the same.

​​Europacific Growth Fund, Greater India Portfolio, Capri Global Holdings and Morgan Stanley Asia Singapore Pte were among the buyers in the deal. Shares of Nuvama Wealth Management rose 0.99% to close at Rs 6,837.15 on Friday.

In a stock exchange filing, Sequent Scientific said its board has approved a proposal to merge Viyash Life Sciences and its group companies, and its wholly owned subsidiary Sequent Research with it.

"The market at this point..(is) pretty much pricing in a soft landing, and pricing in that we have defeated inflation, and that the Fed will be able to lower rates without causing a bunch of harm to the economy", said Liz Young Thomas, head of investment strategy at SoFi in New York.

IDFC Ltd will merge into IDFC First Bank effective October 1, following approval from the National Company Law Tribunal. The merger will dissolve IDFC financial holdings and simplify the corporate structure. IDFC First Bank will issue new equity shares and address accumulated losses, potentially enabling future dividend payments.

Many Asian countries, including India, are moving away from older payment methods like ACH in favor of real-time systems such as UPI. JP Morgan Chase is investing in distributed ledger technology and partnering with ONDC to support this shift and enhance e-commerce and financial services.

HCL Tech and Coforge gained 1.4% and 1.2%, respectively. Mphasis, Persistent Systems, Infosys and Tata Consultancy Services closed between 0.3% and 0.5% higher. Most of these shares traded 2-4% higher earlier in the day.

​​Ascribing sell ratings to Lupin, Dr Reddy’s Laboratories, Zydus Lifesciences and Aurobindo Pharma, the brokerage said the US generic market has been declining and the pace could worsen.

The IPO was a fresh issue of 1.55 crore shares that will fetch Rs 342 crore at the upper price band. The price band was between Rs 209 and Rs 220.